review of glp 1 The expanding role GLP-1 receptor agonists: a narrative of current evidence and future directions Shared earlier this week: GLP-1
Description
Khani M, Afsahi R, Nasab AE, et al
GLP-1 Receptor Agonist Market Highlights: North America registered dominance of the global market share by 76% in 2024

Feb 2018;78(2):275284

Most insurers currently cover GLP-1s, but only for treating diabetes and certain cardiac conditions
[DOI] [PMC free article] [PubMed] [Google Scholar] 68.Abd El Aziz M., Cahyadi O., Meier J.J., Schmidt W.E., Nauck M.A

weight loss therapy is generally not recommended during pregnancy or lactation
